☆ 4.7 Article

Low-dose irradiation for reversing immunotherapy resistance: how to translate?

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Related references

Note: Only part of the references are listed.

Review Immunology

Lighting up the tumor fire with low-dose irradiation

Fernanda G. Herrera et al.

Summary: Recent studies have shown that low-dose radiation therapy effectively activates the immune system and synergizes with immunotherapy, enhancing immune response. These findings help redefine the role of radiation therapy in cancer immunotherapy.

TRENDS IN IMMUNOLOGY (2022)

Add to Collection

Article Oncology

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

Fernanda G. Herrera et al.

Summary: Developing strategies to inflame tumors is critical for increasing response to immunotherapy. Low-dose radiation reprograms the tumor microenvironment to promote T-cell infiltration and, when combined with immunotherapy, simultaneously mobilizes innate and adaptive immunity, predominantly CD4(+) effector T cells, for tumor control dependent on NKG2D. This combination induces important responses in patients with metastatic immune-cold tumors.

CANCER DISCOVERY (2022)

Add to Collection

Meeting Abstract Oncology

Quantifying the impact of the COVID-19 pandemic on gastrointestinal cancer care delivery.

Nicholas Perkons et al.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination

Jiali Yu et al.

Summary: Liver metastases diminish the efficacy of immunotherapy by siphoning activated CD8(+) T cells from systemic circulation, creating systemic immune desert. Combining liver-directed radiotherapy with immunotherapy can promote systemic antitumor immunity.

NATURE MEDICINE (2021)

Add to Collection

Article Oncology

A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

Arta M. Monjazeb et al.

Summary: This study demonstrated the feasibility and safety of adding low-dose fractionated radiation (LDFRT) and hypofractionated radiation (HFRT) to PD-L1/CTLA-4 blockade in patients with metastatic colorectal cancer. While the primary endpoint showed stable disease, biomarkers supported the impact of both LDFRT and HFRT on the immune microenvironment and immunogenicity.

CLINICAL CANCER RESEARCH (2021)

Add to Collection

Article Oncology

Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial

Nasser K. Altorki et al.

Summary: The combination of neoadjuvant durvalumab and stereotactic body radiotherapy in early-stage NSCLC patients shows a high major pathological response rate and is well tolerated, suggesting its potential in treatment, although it comes with certain adverse events.

LANCET ONCOLOGY (2021)

Add to Collection

Article Immunology

Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses

Joyce Wei et al.

Summary: Combining immune checkpoint blockades with radiotherapy may enhance abscopal activity, with the timing of alpha PD-1 antibody administration relative to radiotherapy determining the potency of the induced abscopal response.

SCIENCE IMMUNOLOGY (2021)

Add to Collection

Article Oncology

High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial

Roshal R. Patel et al.

Summary: Early findings from a phase II trial of high-dose radiotherapy (HD-RT) with or without low-dose RT (LD-RT) for metastatic cancer showed that the combination of HD-RT plus LD-RT safely improved lesion-specific response by promoting infiltration of effector immune cells into the tumor microenvironment, providing potential benefit for immune resistant solid tumors.

RADIOTHERAPY AND ONCOLOGY (2021)

Add to Collection

Article Cell Biology

Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade

Ravi B. Patel et al.

Summary: The study demonstrates that delivering radiation semiselectively to tumors through targeted radionuclide therapy (TRT) can enhance response to immune checkpoint inhibitors (ICIs), leading to therapeutic efficacy and tumor-specific T cell memory in murine models. Combination of TRT and ICI activates production of proinflammatory cytokines, promotes tumor infiltration by CD8(+) T cells, and reduces metastases, suggesting a promising approach to improve response to ICIs for various tumor types.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors

Wenyan Zhong et al.

BMC GENOMICS (2020)

Add to Collection

Article Oncology

Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial

Jason J. Luke et al.

CLINICAL CANCER RESEARCH (2020)

Add to Collection

Article Oncology

Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma

Hampartsoum B. Barsoumian et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Add to Collection

Article Oncology

The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors

Luke R. G. Pike et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Add to Collection

Article Oncology

Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Respons

James W. Welsh et al.

CANCER IMMUNOLOGY RESEARCH (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Radiotherapy induces responses of lung cancer to CTLA-4 blockade

Silvia C. Formenti et al.

NATURE MEDICINE (2018)

Add to Collection

Review Oncology

Using immunotherapy to boost the abscopal effect

Wilfred Ngwa et al.

NATURE REVIEWS CANCER (2018)

Add to Collection

Review Oncology

Radiotherapy combination opportunities leveraging immunity for the next oncology practice

Fernanda G. Herrera et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

Add to Collection

Article Multidisciplinary Sciences

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity

Claire Vanpouille-Box et al.

NATURE COMMUNICATIONS (2017)

Add to Collection

Article Oncology

Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment

Yuki Muroyama et al.

CANCER IMMUNOLOGY RESEARCH (2017)

Add to Collection

Article Multidisciplinary Sciences

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy

Kristina H. Young et al.

PLOS ONE (2016)

Add to Collection

Article Oncology

Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade

Simon J. Dovedi et al.

CANCER RESEARCH (2014)

Add to Collection

Article Oncology

[18F] FDG-PET Standard Uptake Value as a Metabolic Predictor of Bone Marrow Response to Radiation: Impact on Acute and Late Hematological Toxicity in Cervical Cancer Patients Treated With Chemoradiation Therapy

Olgun Elicin et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)

Add to Collection

Article Oncology

Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy

Felix Klug et al.

CANCER CELL (2013)

Add to Collection

Article Immunology

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

Eric A. Reits et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.